Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

20 Results

Guidelines and Advice

Complex Malignant Hematology Models of Care: Recommendations for Changes in the Roles and Composition of the Multidisciplinary Team and the Setting of Care to Improve Access for Patients in Ontario – March 2017

Status: Current
ID: GL-C50-31

Mar 2017

Guidelines and Advice

Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology–Cancer Care Ontario Focused Guideline Update

Status: Current
ID: GL-1-A-2016-2

Oct 2017

Guidelines and Advice

Guidance on the Substitution of Systemic Therapy Agents

Status: Current
ID: GL-C50-33
Version: 1

Aug 2017

Guidelines and Advice

Management of Primary Central Nervous System Diffuse Large B-Cell Lymphoma

Status: Current
ID: GL SCT-8

Oct 2017

Guidelines and Advice

Primary Excision Margins and Sentinel Lymph Node Biopsy in Cutaneous Melanoma

Status: Current
ID: 8-2
Version: 2

Nov 2017

Guidelines and Advice

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2017

Status: Current
ID: pet 2017-1

Dec 2017

Guidelines and Advice

Performance of Needle Biopsy of the Prostate for Men with Suspected or Established Prostate Cancer

Status: Current
Version: 1

Sep 2017

Guidelines and Advice

Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-Line Chemotherapy

Status: In-Review
ID: 7-13

Oct 2017

Pages